Загрузка...
Probenecid: An Oral Inotrope for End-Stage Heart Failure in a Case With Myotonic Dystrophy
A 56-year-old man with multiple cardiac manifestations of type 1 myotonic dystrophy, including severe, nonischemic cardiomyopathy, presented in refractory cardiogenic shock requiring inotropic therapy. Given his wishes to die without having any intravenous medications, he was started on oral probene...
Сохранить в:
| Опубликовано в: : | JACC Case Rep |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8301499/ https://ncbi.nlm.nih.gov/pubmed/34316787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaccas.2019.07.008 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|